GlassScriptPhysician profile
Elaine Bylis
NPI 1790207397
$4,807.67
in general payments reported to CMS, 2019-2025
11 companies · $235 in 2025
The $235 reported for 2025 was more than what 79% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $325 · 2021: $336 · 2022: $369 · 2023: $1,880 · 2024: $1,261 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,610 · Travel and Lodging: $1,602 · Gift: $113 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,610.36 |
| Travel and Lodging | $1,602.16 |
| Gift | $112.99 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,724.82 | 2019-2025 | Waveone Gold Conform Fit, Mis, Consumable Dentistry |
| Align Technology, INC. | $1,594.34 | 2019-2025 | Invisalign, Invisalign System - Moderate, Chairside Cad |
| Dentsply LLC | $674.13 | 2024 | |
| Biohorizons Implant Systems INC. | $281.39 | 2019-2022 | |
| Ultradent Products INC | $124.81 | 2022-2023 | Opalescence |
| Straumann USA LLC | $123.37 | 2023 | |
| Geistlich Pharma, North America, INC. | $103.75 | 2025 | Biomaterials |
| Orapharma, A Division of Bausch Health US, LLC | $99.98 | 2019 | |
| Southern Implants North America INC | $50.00 | 2023 | |
| 3m Company | $16.72 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaine Bylis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.